Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Identify Differences of Exhaled Breath Components Using Ion Mobility Spectrometry (IMS) in Patients Tested Positive or Negative on SARS-CoV-2

NCT04556318 is registered in ClinicalTrials.gov with B. Braun Melsungen AG as lead sponsor.

NCT NCT04556318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04556318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Identify Differences of Exhaled Breath Components Using Ion Mobility Spectrometry (IMS) in Patients Tested Positive or Negative on SARS-CoV-2
Lead sponsor
B. Braun Melsungen AG
Phase
Observational
Overall status
Completed
Start date
September 23, 2020
Completion date
June 11, 2021
Enrollment
396 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid19